KENALOG

This brand name is authorized in Canada, Estonia, Croatia, Lithuania, Malta, New Zealand, United Kingdom, United States

Active ingredients

The drug KENALOG contains one active pharmaceutical ingredient (API):

1 Triamcinolone UNII F446C597KA - TRIAMCINOLONE ACETONIDE

Triamcinolone acetonide is a more potent derivative of triamcinolone and is approximately 8 times more potent than prednisone. Although the precise mechanism of corticosteroid anti-allergic action is unknown, corticosteroids are very effective in the treatment of allergic diseases in man. Also, local injections are thought to have an anti-inflammatory effect. Read about Triamcinolone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
KENALOG-10	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
H02AB08	Triamcinolone	H Systemic hormonal preparations, excl. Sex hormones and insulins → H02 Corticosteroids for systemic use → H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN → H02AB Glucocorticoids
Discover more medicines within H02AB08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 01999761, 01999869
Country: EE	Ravimiamet	Identifier(s): 1008425
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 27559
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1013970
Country: MT	Medicines Authority	Identifier(s): AA770/12401
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 113
Country: US	FDA, National Drug Code	Identifier(s): 0003-0293, 0003-0315, 0003-0494, 10631-093, 50090-0256, 50090-0295, 50090-0819, 63187-661, 70518-2460, 76420-085